Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05188079 · ClinicalTrials.gov registry record · NA
Effect of Acute Nitrate Supplementation on Vascular Function in Hispanic, Black and White Population
A NA study of Healthy Adults, sponsored by University of Texas at Austin.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT05188079: Recruiting NA study of Healthy Adults, sponsored by University of Texas at Austin.
NCT05188079 is a NA study of Healthy Adults that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 90 participants, roughly in line with the 84-participant average among 33 other Healthy Adults trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05188079, a NA study of Healthy Adults, is actively recruiting participants, sponsored by University of Texas at Austin.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to assess vascular function in African Americans, Hispanic and Caucasian Americans to better understand racial differences in cardiovascular health. The investigators will further investigate the affect of Beetroot juice on the vascular function of all participants.
Primary Outcome
Blood flow of the brachial artery will be measured continuously at rest, during 3 min of handgrip exercise and for up to 1 min after the cessation of handgrip exercise.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Beetroot juice
- DIETARY_SUPPLEMENT Placebo drink
Study Locations (1)
Texas
- University of Texas at Austin - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2021-10-01 |
| Est. Completion | 2028-01-31 |
| Phase | NA |
What NCT05188079 shows while recruiting
NCT05188079 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, roughly in line with the 84-participant average among 33 other Healthy Adults trials with a reported enrollment target.
The record links to 1 condition, with Healthy Adults appearing as the primary indexed condition, and to 2 interventions - of which Beetroot juice is the first listed.
NCT05188079 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05188079 about?
NCT05188079 is a clinical study titled "Effect of Acute Nitrate Supplementation on Vascular Function in Hispanic, Black and White Population". The purpose of the study is to assess vascular function in African Americans, Hispanic and Caucasian Americans to better understand racial differences in cardiovascular health. The investigators will further investigate the affect of Beetroot juice on the vascular function of all participants.
What is the current status of trial NCT05188079?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2021-10-01. Estimated completion is 2028-01-31.
What conditions does trial NCT05188079 study?
This clinical trial studies the following conditions: Healthy Adults.
What interventions are being tested in trial NCT05188079?
The interventions under investigation include: Beetroot juice (DIETARY_SUPPLEMENT), Placebo drink (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05188079?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05188079 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Adults
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05188079's enrollment target sits among peer trials
90 10th of 33 higher than 24 of 33 other Healthy Adults trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Adults trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Breathing Training and Nitrate on Exercise at Simulated Altitude
RECRUITING · NA
-
Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines
RECRUITING · NA
-
Health Properties of Pecan Nut Consumption
RECRUITING · NA
-
The Brain Processes Underlying Speech Motor Learning and Speech Production
RECRUITING · NA
-
Pilot Study of the Entarik System With Advanced Functionality in Health Adults
RECRUITING · NA
-
Phase 2 Seattle Dietary Biomarkers Development Center
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI